tHEORetically Speaking
Menu Close
  • Home
  • Guest Authors
  • About Us
  • HealthEconomics.Com
  • HE Jobs Portal

health reform

0

The Problem with Preventive Medicine

Posted on April 18, 2013 by Nicholas Emptage

The passage of the ACA in 2010 has to feel like a high-water mark for proponents of preventive medicine. The Obama health reform essentially makes free preventive care the law of the land, with insurers required to completely cover the… Continue Reading →

Guest Bloggers economics, Evidence-based medicine, health economics, health reform, prevention
0

The Affordable Care Act: Perfect? Hardly.

Posted on April 12, 2013 by Debra Gordon

I did a radio interview last week with KZYX public radio in Mendocino, CA. The topic was one near and dear to my heart – the Affordable Care Act (ACA). Towards the end of the show, the host asked me… Continue Reading →

Guest Bloggers ACA, affordable care act, care, costs, health reform, healthcare costs, hospital, insurance, mandate, PPACA, readmission, reimbursement

About the HealthEconomics.Com Blog:

Insights, observations, executive interviews, critical analysis, and new research for health economics, outcomes research, real-world evidence, and market access community. We welcome guest bloggers.

Check your inbox or spam folder to confirm your subscription.

Recent Posts

  • Will 2023 Be the Year AI Disrupts Healthcare?
  • Real-World Data Can Bring Value to Life Sciences Companies Operating in a Value-Based World
  • Podcast Q&A: Achieving Consensus When Everyone is an Expert, but No One Agrees
  • Podcast Q&A: Social Media Data: Opportunities and Insights for Clinical Research

HealthEconomics.Com Twitter Feed

HealthEconomics.Com | A Scientist.com Company Follow

www_healthecon
www_healthecon HealthEconomics.Com | A Scientist.com Company @www_healthecon ·
4h

How are #payers reacting to the Inflation Reduction Act? Help us find out! - https://mailchi.mp/healtheconomics.com/how-are-payers-reacting-to-the-inflation-reduction-act-help-us-find-out #marketaccess #pharma

Reply on Twitter 1620769094160064513 Retweet on Twitter 1620769094160064513 Like on Twitter 1620769094160064513 Twitter 1620769094160064513
www_healthecon HealthEconomics.Com | A Scientist.com Company @www_healthecon ·
17h

Boehringer Ingelheim Reveals Positive Trial Results for Rare Psoriasis Therapeutic

http://ow.ly/6yf050MG6if

#HEOR #RareDisease #Therapeutics #ClinicalTrials #Research

Reply on Twitter 1620567651561906180 Retweet on Twitter 1620567651561906180 Like on Twitter 1620567651561906180 Twitter 1620567651561906180
www_healthecon HealthEconomics.Com | A Scientist.com Company @www_healthecon ·
18h

Moderna and Pfizer COVID-19 Vaccine 4X Price Increase Worries UK and US Lawmakers

http://ow.ly/hlAo50MG413

#HEOR #Vaccines #COVID19 #DrugPrices #DrugPricing

Reply on Twitter 1620552552113750016 Retweet on Twitter 1620552552113750016 Like on Twitter 1620552552113750016 Twitter 1620552552113750016
Load More...

Archives

Visit our website, HealthEconomics.Com, top ranked by Google for news, jobs and resources in healthcare value, market access and more. Read our privacy policy here.
© 2023 tHEORetically Speaking. All rights reserved.
Hiero by aThemes